ADT for Prostate Cancer: Concern That Injections Often Given Late – Medscape
Posted: July 31, 2020 at 12:56 pm
The objective of androgen deprivation therapy (ADT) in men with prostate cancer is to maintain very low levels of testosterone so that the hormone does not promote tumor growth. But a new analysis found that drugs commonly used to achieve this are administered later than the recommended 28-day regimen, and this late dosing was associated with ineffective suppression of testosterone.
"Evidence suggests achieving and sustaining T levels <20 mg/dL with ADT is desirable and correlates with improved disease-specific survival in patients with advanced prostate cancer," lead author David Crawford, MD, professor of urology, University of California, San Diego, and colleagues point out.
They looked at administration schedules for luteinizing hormone-releasing hormone (LHRH) agonists and found that they were frequently (84%) administered later than the recommended schedule of every 28 days. Nearly half of the late testosterone values for the extended month were greater than 20 ng/dl, and mean testosterone was almost double the castration level, they report.
"Considering the presumed clinical benefits of maintaining effective T suppression throughout the course of ADT, clinicians should administer treatments within approved dosing instructions, monitor T levels, and consider prescribing treatments with proven efficacy through the dosing interval to maintain T below castration levels," they emphasize.
The analysis was published in the Journal of Urology and was presented during the virtual American Urological Association 2020 annual meeting.
The study was done before the current pandemic, which canceled the in-person gathering of AUA 2020. Now, in the COVID-19 era, the interval between when men are scheduled for their next injection and when they actually get it may well be growing longer. Crawford says he recently saw one patient who waited 3 months before getting his next "monthly" injection.
For the review, Crawford and colleagues examined electronic health records (EHRs) and associated insurance claims for a total of 85,030 injections to evaluate the frequency of late dosing.
When the pivotal registration trials for LHRH agonist were done, a 1-month injection of an LHRH formulation was defined as every 28 days, and not 30 or 31 days as per calendar months.
The current analyses were done using 2 definitions of a month: a 28-day month with late dosing defined as injections given after day 28, and an "extended" month with late dosing defined as injections given after day 32, for products that are dosed once-monthly. The analyses also looked at products that are dosed once every 3-months, once every 4 months, and once every 6 months.
The team also evaluated how often testosterone exceeded the castration level of 20 ng/dL, as well as mean T levels and frequency of T tests and prostate specific antigen (PSA) tests taken by physicians prior to administering the injection.
Results showed that 84% of the 28-day dosing interval and 27% of the extended-month dosing administrations were late.
Furthermore, "when LHRH agonist dosing was late, both the proportion of T tests with T >20 ng/dL and mean T were higher compared to when the dosing was early or on-time," Crawford and colleagues point out.
For example, 43% of T values exceeded 20 ng/dL when injections were late compared to only 21% of T values when injections were given early or on time.
Furthermore, mean T values were 21 ng/dL when injections were given early or on time, but they rose to a mean of 79 ng/dL when injections were late.
Physicians were also far less likely to measure T levels at the time of administering the injections when compared to measuring PSA levels, the team found. T levels were assessed only 13% of the time, whereas PSA levels were assessed 83% of the time while administering LHRH injections.
"All of the package inserts say clinicians should measure T periodically when men are on these drugs, yet urologists don't do it most of the time. They are more interested in PSA because that is what the patient wants to know," Crawford commented in an interview with Medscape Medical News.
The thinking is that "so as long as the PSA is fine, everything else is fine too," he added.
That, however, is not necessarily the case.
As Crawford and his colleagues explain, rising PSA levels can reflect disease progression to castrate-resistant prostate cancer but they may also simply reflect late ADT dosing or other technical issues such as inappropriate dosing for a patient's body weight.
With a number of new therapies now available for castrate-resistant prostate cancer, it's important that physicians ensure that T levels remain below castration levels in order to not wrongly diagnose a man with castrate resistance disease as subsequent changes in management could be entirely inappropriate.
More of an issue, Crawford suggests, is that every time a patient receives an injection of an LHRH agonist, not only do his T levels flare, but so does his PSA.
Crawford suspects that levels of follicle-stimulating hormone (FSH) are also going up in response to LHRH agonist injections.
"We know that hormone therapy is associated with a lot of side effects but the big one for us right now is cardiovascular, so you may be doing the patient a significant disservice by allowing these 'mini-flares' to occur with late injections," Crawford said.
As to why men are receiving their injections beyond recommended intervals, Crawford feels that many urologists are not taking the timing of dosing as seriously as they should.
"There may also be scheduling issues and patient compliance issues as well," he acknowledged.
Disturbingly, however, if a man does show up in a timely way for his next injection, "insurance companies may refuse to reimburse him unless he comes back on days 30 or 31," Crawford observed.
For men who are concerned about COVID-19 and reluctant to attend the clinic for the next injection, there are ways to deliver healthcare that can facilitate timely dosing.
For example, some big urology clinics are having men drive up to their parking lots and receive their next injection in the car, by appointment only of course. Some centers are trying out at home administration.
The other solution to the late dosing problem is to prescribe longer-acting depot formulations so men need less frequent infections.
"It is simply not acceptable to be giving drugs out of their indication and time frame for which they were approved, so people need to take this more seriously," Crawford said.
"We need to administer these drugs on time," he emphasized.
"We need to monitor T levels because some patients will still experience escapes even if they are getting the drug on time," Crawford explained, "and we now have evidence that when patients do have these T failures, this is reflected in rising PSA levels and that may be an indication of disease progression, which we clearly don't want to happen."
The study was funded by Tolmar. Crawford reports receiving fees from Tolmar and Ferring. The other study authors have disclosed no relevant financial relationships.
The American Urologist Association (AUA) 2020 Annual Meeting: Abstract MP37-18.
J Urol. Published online April 1, 2020. Abstract
For more from Medscape Oncology, join us on Twitter and Facebook
Read more from the original source:
ADT for Prostate Cancer: Concern That Injections Often Given Late - Medscape
- Denial of hormones is more than women should bear - The Medical Republic - February 23rd, 2024
- Katy couple discovers benefits of hormone replacement therapy - FOX 26 Houston - February 13th, 2024
- Gender-affirming care clinic in Thunder Bay, Ont., closes, leaving patients with limited options - CBC.ca - February 5th, 2024
- What It Means That Lisa Rinna Is On HRT For Menopause - Women's Health - January 11th, 2024
- Lisa Rinna Was Initially 'Very Scared' of Hormone Replacement Therapy. She Isn't the Only One - The Messenger - January 11th, 2024
- MrBeast's Kris Tyson Shares Before and After Photos Following 1 Year of Hormone Replacement Therapy - PEOPLE - January 11th, 2024
- Lisa Rinna Was 'Really Scared' to Undergo Hormone Replacement Therapy for Menopause Symptoms: 'I Haven't ... - Yahoo Entertainment - January 11th, 2024
- Kris Tyson Before And After HRT Pictures - BuzzFeed - January 11th, 2024
- Hormone replacement therapy and early menopause tied heightened risk of rheumatoid arthritis - Medical Dialogues - January 11th, 2024
- Open for Business: Alpine Wellness opens new clinic for integrative medicine and hormone health - KOLO - January 3rd, 2024
- Is Hormone Replacement Therapy Right for You? What to Know - Motherly Inc. - January 3rd, 2024
- Easy as visiting the GP: Doctors push for accessible hormone treatment as childrens waitlist swells - The Age - January 3rd, 2024
- How to Balance Hormones: 11 Nondrug and Drug Options - Verywell Health - December 25th, 2023
- Hormone Replacement Therapy Market Poised for a Remarkable US$ 23,729.6 Million Valuation by 2034, Fueled by a ... - Yahoo Finance - December 25th, 2023
- Home - CHS Hormone - December 6th, 2023
- My teenage son was indoctrinated by the trans cult from the classroom to the clinic: Mother left 'grieving' fo - Daily Mail - November 27th, 2023
- Hormone Evaluation and Replacement Therapy | Amen Clinics - November 2nd, 2023
- Depression can hit hard during the winter months, here's how to prevent it - NewsCenterMaine.com WCSH-WLBZ - October 16th, 2023
- As a study finds a stable weight is key to living longer, a leading nutritionist's guide on how to... Escape t - Daily Mail - October 16th, 2023
- I worked at the Tavistock gender clinic. Closing it was the right move - The Dallas Morning News - April 26th, 2023
- What causes hormonal imbalance and how to avoid it? - GMA News Online - March 23rd, 2023
- Thyroid Hormone: What It Is & Function - Cleveland Clinic - December 20th, 2022
- Menopause - Symptoms and causes - Mayo Clinic - December 20th, 2022
- Human Chorionic Gonadotropin: Hormone, Purpose & Levels - Cleveland Clinic - December 20th, 2022
- Polycystic ovary syndrome (PCOS) - Symptoms and causes - Mayo Clinic - December 20th, 2022
- Hypothyroidism: Symptoms, Causes, Treatment & Medication - Cleveland Clinic - December 20th, 2022
- Postpartum depression - Symptoms and causes - Mayo Clinic - December 20th, 2022
- Let's Talk Sex | Unpacking the Mystery of PCOS: Causes, Symptoms and Treatments - News18 - December 20th, 2022
- Masculinizing hormone therapy - Mayo Clinic - October 16th, 2022
- Human Growth Hormone (hGH) - Cleveland Clinic - October 16th, 2022
- Chronic stress puts your health at risk - Mayo Clinic - October 16th, 2022
- Menstrual Migraines (Hormone Headaches) - Cleveland Clinic - October 16th, 2022
- Acromegaly: What It Is, Causes, Symptoms & Treatment - Cleveland Clinic - October 16th, 2022
- Hormone Therapy and Shoulder Pain During Menopause - Healthline - October 16th, 2022
- CHOICES Reproductive Health clinic now open in Carbondale - WSIL TV - October 16th, 2022
- Helping Reduce Your Risk of Breast Cancer ThedaCare - ThedaCare - October 16th, 2022
- HIV patients abused and humiliated - News24 - October 16th, 2022
- Recommended Approaches to Treatment for Early-Stage HER2+ Breast Cancer - Targeted Oncology - October 16th, 2022
- Diabetes and the gut: How a bacterial protein may impact insulin - Medical News Today - October 16th, 2022
- TUCKER CARLSON: The Democratic Party is replacing parents with itself - Fox News - October 16th, 2022
- 'You will get your heart broken. Not might, will.': Foster mom shares heartwarming adoption after infertility, heartbreak - Love What Matters - October 16th, 2022
- Everything You Need To Know About Hormone Replacement Therapy - Health Digest - August 11th, 2022
- What is hormone therapy for breast cancer? - MD Anderson - August 11th, 2022
- Brevard LGBTQ clinic responds to proposed restrictions on trans healthcare - Florida Today - August 11th, 2022
- Aldosterone, a hormone that prevents dehydration, is linked to worsening kidney disease, study suggests - STAT - August 11th, 2022
- 8 reasons why you wake up tired, and how to fix it - WDJT - August 11th, 2022
- What We Learned About Steve Jobs' Health After His Death - Health Digest - August 11th, 2022
- Hormonal Acne: Causes, Treatment, And How To Prevent It - Women's Health - August 11th, 2022
- Bastion Health Announces the addition of Dr. Justin Houman as Medical Director - PR Web - August 11th, 2022
- Lanta Flat Belly Shake Reviews - Really Effective for Weight Loss? Urgent Customer WARNING - Outlook India - August 11th, 2022
- Some Women Turn to Self-Managed Abortion as Access Recedes - The New York Times - August 11th, 2022
- Can I Still Get the Abortion Pill? Everything to Know - CNET - August 11th, 2022
- Why You Need To Stop Using Your Android Phone Before Going To Sleep - SlashGear - August 11th, 2022
- What the Tavistock clinics closure means for the trans debate - The Week UK - August 3rd, 2022
- India's First Trans Trainee Pilot Adam Harry's Case That Led DGCA To Work On Policy For Trans Pilots - Outlook India - August 3rd, 2022
- 6 Medical Conditions That Can Cause You to Gain Weight - SciTechDaily - August 3rd, 2022
- Guideline change removes 'demeaning' barrier to hormone therapy - Stuff - August 3rd, 2022
- Injectable HIV Prevention Better Than Pills in Two Trials - Medscape - August 3rd, 2022
- I Tested My Stress and It Was Through the RoofHeres the Expert-Backed Plan Thats Getting Me Through It - Well+Good - August 3rd, 2022
- 7 home remedies for crows feet to keep wrinkles and fine lines at bay - Health shots - August 3rd, 2022
- The Real Effects Owning A Pet Has On Your Body - Health Digest - August 3rd, 2022
- Lets Talk About Misoprostolthe Original Abortion Pill - Ms. Magazine - August 3rd, 2022
- This Period-Tracking Method Will Protect Your Privacy Better Than an App - CNET - August 3rd, 2022
- The circulating 70 kDa heat shock protein (HSPA1A) level is a potential biomarker for breast carcinoma and its progression | Scientific Reports -... - August 3rd, 2022
- Hormone Therapy for Menopause Symptoms - Cleveland Clinic - June 28th, 2022
- Hormone therapy for breast cancer - Mayo Clinic - June 28th, 2022
- Gonadotropin-Releasing Hormone (GnRH): Purpose & Testing - June 28th, 2022
- Family Tree Clinic has broadened its scope of services and its regional impact by helping transgender people get the hormone care they need - Sahan... - June 28th, 2022
- Hot Flashes From Hormone Therapy, Poorer Outcomes in Breast Cancer - Medscape - June 28th, 2022
- Smartphone use increases urination at night: nutritionist - - June 28th, 2022
- How To Track Your Ovulation Most Accurately, According To Ob-Gyns - Women's Health - June 28th, 2022
- Anti-Abortion Centers Find Pregnant Teens Online, Then Save Their Data - Bloomberg - June 28th, 2022
- The most common birth control methods and how effective they are at preventing pregnancy - Yahoo Life - June 28th, 2022
- The Journey To Be Me: The heartbreak, hope and courage of a Maine transgender child - Maine Public - June 18th, 2022
- How To Reintroduce Lactation After Stopping Breastfeeding - Health Essentials from Cleveland Clinic - June 18th, 2022
- Medication abortions are easy to access in Oregon, but how do they work? - Oregon Public Broadcasting - June 18th, 2022
- How does an IUD work and how long does it last? - Reviewed - June 18th, 2022
- Men's Wellness: Being proactive, annual care key to maintaining health - LimaOhio.com - June 18th, 2022
- Hormone-Replacement Therapy Is Life-Changing: What to Consider Before Getting Started - POPSUGAR - June 9th, 2022
- Do You Need Hormone Testing? - Health Essentials from Cleveland Clinic - June 9th, 2022